NAIROBI, KENYA
Kenya has confirmed a second death from Ebola, intensifying concerns over the spread of the deadly virus across Africa, although health authorities insist there is currently no evidence of wider community transmission. The Ministry of Health announced on Friday, October 23, that a 65-year-old woman had died while receiving treatment for Bundibugyo virus disease, a rare form of Ebola.
The deceased was a close relative and direct contact of Kenya’s first Ebola patient, a man who contracted the virus after travelling from the Democratic Republic of the Congo. According to Director-General for Health Dr Patrick Amoth, the woman was already under quarantine when she developed symptoms on October 13. She was immediately admitted to an infectious disease treatment facility, where medical teams provided supportive care.
Despite efforts to save her life, her condition deteriorated, and she died on Friday evening. Her death brings Kenya’s confirmed Ebola fatalities to two out of nine infections. Seven patients remain under treatment at two designated isolation facilities. The ministry maintained that all confirmed infections belong to a single cluster involving people previously identified as contacts of the first patient. Authorities have traced and quarantined 135 individuals who may have been exposed to the virus. Officials emphasised that detecting infections among monitored contacts does not establish uncontrolled community transmission.
However, they warned that additional cases could emerge during the observation period. The ministry is coordinating with the deceased woman’s family to arrange a safe and dignified burial under established infection-prevention protocols. The latest development follows Kenya’s first confirmed Ebola death on October 5, involving a 40-year-old man who had travelled from Congo through Uganda before arriving in Nairobi.
Meanwhile, the World Health Organization reports that the wider Bundibugyo outbreak has caused thousands of deaths in the Democratic Republic of the Congo. As of October 20, Congo had recorded 9,704 confirmed infections and 4,687 deaths. WHO has urged affected countries to strengthen surveillance, contact tracing, laboratory testing and cross-border cooperation. The Bundibugyo virus currently has no approved vaccine or specific antiviral treatment, although early diagnosis and intensive supportive care can improve survival.
Health authorities have advised the public to avoid direct contact with the bodily fluids of infected individuals, practise proper hygiene and seek medical attention when symptoms develop. Common symptoms include fever, weakness, vomiting, diarrhoea and, in severe cases, unexplained bleeding. Despite the second death, Kenyan officials say containment measures remain active, with continued monitoring intended to prevent infections from spreading beyond the identified cluster.



















